Pulmonx Corporation LUNG Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulmonx Corporation's additional paid-in capital?
- Pulmonx Corporation (LUNG) reported additional paid-in capital of $578.76M in Q1 2026.
- How has Pulmonx Corporation's additional paid-in capital changed year-over-year?
- Pulmonx Corporation's additional paid-in capital increased by 3.8% year-over-year, from $557.43M to $578.76M.
- What is the long-term trend for Pulmonx Corporation's additional paid-in capital?
- Over 5 years (2020 to 2025), Pulmonx Corporation's additional paid-in capital has grown at a 4.2% compound annual growth rate (CAGR), from $467.15M to $573.27M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.